Skip Navigation

European Heart Journal 1988 9(12):1284-1290;
Copyright © 1988 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by PRIESTLEY, K.A.
Right arrow Articles by CURRY, P.V.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by PRIESTLEY, K.A.
Right arrow Articles by CURRY, P.V.L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1988 The European Society of Cardiology

Experience with flecainide for the treatment of cardiac arrhythmias in children

K.A. PRIESTLEY*,, E.J. LADUSANS{dagger}, E. ROSENTHAL*, D.W. HOLT{ddagger}, M.J. TYNAN{dagger}, O.D.H. JONES{dagger},1 and P.V.L. CURRY*

*Departments of Cardiology London, U.K.
{dagger}Paediatric Cardiology and the Poisons Unit London, U.K.
{ddagger}Guy's Hospital London, U.K.

Received 24 February 1988; revised 24 June 1988; .

Dr K.A. Priestley, Department of Cardiology, Guy's Hospital, St.Thomas Street, London SEI 9RT, U.K.

Abstract

We treated 22 children, aged 3 days to 16 years 6 months (medium 11 years 1 month), with flecainide for a variety of aryhythmias where a Class I agent was indicated in 16, conventional antiarrhythmic treatment had failed. Structural heart disease was present in nine. The arrhythmia was paroxysmal re-entry atrioventricular tachycardia in five and frequent ventricular extrasystoles (with couplets) in three. Sinas rhythm was achieved in all four children who received flecainide during tachycardia (three received intravenous flecainide during tachycardia (three received intravenous flecainide, one oral). During follow-up of 3–24 months (median 12 months), arrhythmia control was obtained in 13 children (59%). Combination therapy was used in seven of these; with digoxin in four and a beta blocker in three. Flecainide doses used in this study ranged from 1–11 mg kg–1 day–1 (median 4 mg kg–1 day–1), 25–297 mg m–2 day–1).The medium, pre-dose flecainide concentration in those responding to therapy was 225 µgl–1 and in those failing to respond was 417 µgl–1. An arrhythmogenic effect occured in one child.

Key Words: Flecainide, • arrhytyhmia, • child.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.